In a nationally representative survey of 2,000 single U.S
Identifying Good Candidates for Semaglutide A semaglutide weight loss program may be ideal if your BMI is 30 or above, or 27 and accompanied by a related condition like type 2 diabetes
Typically administered as an injection
One understanding of your full health picture
GLP-1 and its mechanisms of regulation and synthesis GLP-1 is a peptide hormone produced by the enzymatic breakdown of proglucagon
Quarterly sales of Novo Nordisks Wegovy in 2022 and 2024, Statista (2024) Contrave, DailyMed (2024) Wegovy, DailyMed (2024) Prescription medications to treat overweight & obesity, National Institute of Diabetes and Digestive and Kidney Diseases (2024) Why obesity is a disease, Obesity Medicine Association (2023) AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity, Gastroenterology (2022) Naltrexone/bupropion ER (Contrave), Pharmacy & Therapeutics (2016) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice